Mounjaro®
Starting from £179.99/mo
Start journey Learn moreNausea is the most commonly reported side effect when stepping up to 7.5mg tirzepatide, and it can catch people off guard even if the earlier doses felt manageable. Most people find it settles within one to two weeks as the body adjusts to the new dose level. These medicines are prescription-only and assessed by a clinician before any dose change, so if your nausea feels severe or is not improving, the right move is to contact your prescriber rather than push through alone.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
You managed 5mg reasonably well, perhaps with a bit of queasiness in the first week, but now the sickness feels more pronounced. That reaction is genuinely common at this step. Tirzepatide activates both GIP and GLP-1 receptors in the gut, which slows how quickly food moves from your stomach into your small intestine. That slowing is part of what reduces appetite, but it also means your stomach stays fuller for longer, and nausea follows. At 7.5mg the signal to those receptors is stronger than it was at 5mg, so the body takes time to recalibrate.
The NHS patient information on tirzepatide lists nausea, vomiting and stomach discomfort as common effects, particularly at the start of treatment or after a dose increase. The key word is after: symptoms tend to cluster in the days immediately following an injection, then fade before the next weekly dose is due. If you are on day two or three and feeling rough, you are likely in the thick of it rather than facing something that will last indefinitely.
One thing worth knowing: the 7.5mg dose is still considered part of the titration phase, not the end point. Your prescriber's goal is to find the dose that works for your body, not to push you to the highest one regardless of how you feel. Details on what the full 7.5mg schedule looks like are covered on the 7.5mg Mounjaro page.
Several habits that felt fine at lower doses can become problems at 7.5mg, largely because the gastric-emptying effect is more pronounced. Large meals are the biggest trigger: when the stomach empties slowly, a big portion can sit there long enough to cause real discomfort. Rich, fatty foods compound the effect. So does eating quickly, lying down within an hour of a meal, and drinking a lot of liquid during food rather than between meals.
Timing also matters more than people expect. Alcohol, fizzy drinks and foods that are very sweet or very spicy all tend to provoke the gut when it is already under the influence of tirzepatide. Some people find that eating something small and bland at lunchtime rather than waiting for a large evening meal keeps things more settled across the day.
Hydration deserves a mention of its own. Nausea can reduce the appetite for fluids as well as food, and mild dehydration then makes nausea worse. Small, regular sips throughout the day tend to work better than trying to drink a full glass and feeling worse for it. If you are vomiting repeatedly and struggling to keep fluids down, that moves beyond ordinary nausea and you should contact your GP or prescriber the same day. Information on how nausea commonly presents at the previous dose rung is on the 5mg nausea page, which may give you a useful comparison.
Ordinary nausea that peaks around days two and three, then fades to background discomfort by day five or six, is the pattern most people describe. It does not require stopping treatment or delaying your next injection, though it does require some practical management. Keeping a brief note of when symptoms appear and how severe they feel can help your prescriber make informed decisions about whether to hold the dose, slow the titration or adjust anything else.
There are signs that should prompt you to get advice sooner rather than later. Severe, persistent stomach pain that spreads toward the back is a red flag for pancreatitis, which is a rare but serious side effect the MHRA highlighted in a Drug Safety Update in January 2026. This is different from the usual queasiness: the pain tends to be constant rather than wave-like, and it does not ease. Signs of significant dehydration from repeated vomiting, including dizziness, very dark urine or not needing the bathroom for many hours, also need same-day attention.
If you are finding that nausea at 7.5mg is affecting your ability to eat or drink at all, a conversation with your prescriber is the right next step. Holding at 7.5mg for longer than the standard four weeks is a clinically reasonable option if it means you can tolerate the dose comfortably before moving further. You do not have to white-knuckle through this alone. The Mounjaro overview has a broader picture of how the dose schedule typically progresses.
A few adjustments work reliably for most people. Eat smaller portions, more frequently, rather than two or three large meals. Front-load your protein at each sitting so that even if you manage only a small amount before feeling full, you have had something nutritious. Many people find cold or room-temperature food easier to tolerate than hot dishes when nausea is at its peak, partly because hot food has a stronger smell.
Plain, easily digestible food is not glamorous advice, but it genuinely helps: rice, plain pasta, toast, boiled potatoes, crackers. Avoid skipping meals entirely even when you feel sick; an empty stomach can actually worsen nausea. Ginger, whether as a tea, biscuit or supplement, has modest evidence behind it for nausea generally, and many people on tirzepatide find it useful as a supplement to other measures — though it is not a medical treatment.
Think about when in the week you inject, too. If you know the second and third days tend to be rough, scheduling your injection for a Thursday evening means the worst of it falls over a weekend when you may have more flexibility around meals and rest. If your circumstances are different, adjusting the injection day in consultation with your prescriber is a straightforward option. For those considering what else comes with tirzepatide treatment, there is more on the cost and service side at the treatment overview page. And if hunger between doses is something you are also navigating, our page on feeling hungry at the starting dose of Mounjaro covers the underlying reasons in more detail, including how appetite signals tend to shift as the dose increases.
Most people who get through the 7.5mg adjustment period do find that the nausea becomes noticeably more manageable. The body does adapt. Speaking to a prescriber before concluding that this dose is not for you is almost always worth doing first.
If you have not yet spoken to a prescriber about your experience, or if you are looking to start tirzepatide with proper clinical oversight, you can start your free consultation with our team today. Some people also ask whether the medication has wider hormonal effects, and we have a dedicated page covering whether tirzepatide increases testosterone, which may be relevant depending on your health goals.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.